Keith A Johnson
#130,508
Most Influential Person Now
Researcher
Keith A Johnson's AcademicInfluence.com Rankings
Keith A Johnsonchemistry Degrees
Chemistry
#3030
World Rank
#4011
Historical Rank
Organic Chemistry
#470
World Rank
#546
Historical Rank
Keith A Johnsonbiology Degrees
Biology
#8580
World Rank
#11679
Historical Rank
Molecular Biology
#1098
World Rank
#1123
Historical Rank
Neuroscience
#1190
World Rank
#1234
Historical Rank
Download Badge
Chemistry Biology
Keith A Johnson's Degrees
- Masters Biology Stanford University
Similar Degrees You Can Earn
Why Is Keith A Johnson Influential?
(Suggest an Edit or Addition)Keith A Johnson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease (2009) (2520)
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers (2016) (1004)
- Amyloid Deposition Is Associated with Impaired Default Network Function in Older Persons without Dementia (2009) (898)
- Tau positron emission tomographic imaging in aging and early Alzheimer disease (2016) (737)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Brain imaging in Alzheimer disease. (2012) (648)
- Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue (2015) (553)
- The Evolution of Preclinical Alzheimer’s Disease: Implications for Prevention Trials (2014) (543)
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET (2015) (536)
- Functional Alterations in Memory Networks in Early Alzheimer’s Disease (2010) (518)
- CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology (2013) (459)
- Imaging of amyloid burden and distribution in cerebral amyloid angiopathy (2007) (398)
- Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease (2019) (389)
- Subjective cognitive complaints and amyloid burden in cognitively normal older individuals (2012) (385)
- P2-366 Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees (2006) (367)
- Appropriate Use Criteria for Amyloid PET: A Report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer’s Association (2013) (364)
- Cognition, Reserve, and Amyloid Deposition in Normal Aging (2009) (363)
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association (2013) (362)
- Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. (2007) (349)
- Neuronal dysfunction and disconnection of cortical hubs in non-demented subjects with elevated amyloid burden (2011) (326)
- Executive function and instrumental activities of daily living in mild cognitive impairment and Alzheimer's disease (2011) (323)
- Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease. (2011) (322)
- Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease (2013) (318)
- Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly (2011) (315)
- Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. (2014) (277)
- Preclinical Alzheimer disease—the challenges ahead (2013) (245)
- Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease (2014) (240)
- Stepwise Connectivity of the Modal Cortex Reveals the Multimodal Organization of the Human Brain (2012) (230)
- Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease (2017) (214)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline (2012) (198)
- Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging (2013) (197)
- Resistance to autosomal dominant Alzheimer’s in an APOE3-Christchurch homozygote: a case report (2019) (196)
- Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer’s disease (2011) (191)
- Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy (2010) (190)
- Different partial volume correction methods lead to different conclusions: An 18F-FDG-PET study of aging (2016) (189)
- Partial volume correction in quantitative amyloid imaging (2015) (182)
- Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression. (2015) (176)
- Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals (2017) (175)
- Imaging markers for Alzheimer disease (2013) (174)
- Pathological correlations of [F‐18]‐AV‐1451 imaging in non‐alzheimer tauopathies (2017) (173)
- Structural tract alterations predict down-stream tau accumulation in amyloid positive older individuals (2018) (169)
- Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases. (2016) (167)
- Face-name associative memory performance is related to amyloid burden in normal elderly (2011) (166)
- Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease (2013) (165)
- Cognitive Profile of Amyloid Burden and White Matter Hyperintensities in Cognitively Normal Older Adults (2012) (164)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Brain amyloid and cognition in Lewy body diseases (2012) (156)
- Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. (2014) (151)
- Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education (2013) (148)
- Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia (2013) (147)
- Impaired default network functional connectivity in autosomal dominant Alzheimer disease (2013) (146)
- Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy. (2015) (145)
- Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults (2019) (145)
- In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain (2016) (141)
- Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts (2018) (140)
- Multiple Brain Markers are Linked to Age-Related Variation in Cognition. (2016) (140)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. (2018) (136)
- Association of Higher Cortical Amyloid Burden With Loneliness in Cognitively Normal Older Adults. (2016) (134)
- The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals (2018) (134)
- Interactive Associations of Vascular Risk and &bgr;-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study (2018) (133)
- Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study (2013) (130)
- Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease (2018) (128)
- Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals. (2020) (125)
- 18F‐flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study (2017) (124)
- Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals (2013) (124)
- Subjective cognitive concerns, amyloid-β, and neurodegeneration in clinically normal elderly (2015) (115)
- Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy (2012) (115)
- Neurogenetic contributions to amyloid beta and tau spreading in the human cortex (2018) (114)
- Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β (2017) (114)
- Harvard Aging Brain Study: Dataset and accessibility (2017) (113)
- Perfusion abnormalities in prodromal AD (2000) (108)
- Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimer’s Continuum (2012) (108)
- Fluorodeoxyglucose metabolism associated with tau‐amyloid interaction predicts memory decline (2017) (107)
- Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants (2014) (105)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global &bgr;-Amyloid Burden (2017) (103)
- Odor identification and Alzheimer disease biomarkers in clinically normal elderly (2015) (102)
- CD33 modulates TREM2: convergence of Alzheimer loci (2015) (101)
- In vivo characterization of the early states of the amyloid-beta network. (2013) (99)
- Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly (2016) (97)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Detection of isolated cerebrovascular β‐amyloid with pittsburgh compound B (2008) (93)
- Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study (2016) (92)
- Mild to moderate Alzheimer dementia with insufficient neuropathological changes (2014) (91)
- Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue (2019) (88)
- PET staging of amyloidosis using striatum (2018) (83)
- Flortaucipir tau PET imaging in semantic variant primary progressive aphasia (2017) (83)
- Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson’s case (2017) (82)
- Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. (2014) (80)
- Functional network integrity presages cognitive decline in preclinical Alzheimer disease (2017) (78)
- Depressive Symptoms and Biomarkers of Alzheimer's Disease in Cognitively Normal Older Adults. (2015) (78)
- Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects (2017) (77)
- Failure to Modulate Attentional Control in Advanced Aging Linked to White Matter Pathology (2011) (75)
- MRI-guided SPECT perfusion measures and volumetric MRI in prodromal Alzheimer disease. (2003) (74)
- Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease (2018) (74)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography (2021) (74)
- Florbetapir-PET to diagnose cerebral amyloid angiopathy (2016) (73)
- A concise radiosynthesis of the tau radiopharmaceutical, [(18) F]T807. (2013) (73)
- Age and amyloid-related alterations in default network habituation to stimulus repetition (2012) (73)
- Tau and amyloid β proteins distinctively associate to functional network changes in the aging brain (2017) (72)
- Amyloid Deposition Is Linked to Aberrant Entorhinal Activity among Cognitively Normal Older Adults (2014) (71)
- Biomarkers of Alzheimer Disease: Current and Future Applications to Diagnostic Criteria (2013) (71)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults. (2019) (69)
- The association between tau PET and retrospective cortical thinning in clinically normal elderly (2017) (69)
- The role of neuroimaging in elucidating delirium pathophysiology. (2006) (68)
- White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease (2018) (68)
- Update on Appropriate Use Criteria for Amyloid PET Imaging: Dementia Experts, Mild Cognitive Impairment, and Education (2013) (67)
- Preferential degradation of cognitive networks differentiates Alzheimer’s disease from ageing (2018) (63)
- Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity (2018) (63)
- Vascular Risk and β‐Amyloid Are Synergistically Associated with Cortical Tau (2019) (63)
- The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment. (2015) (62)
- Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging (2017) (62)
- Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals. (2016) (62)
- Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study. (2017) (61)
- Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults (2019) (61)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- 18F-Flortaucipir Binding in Choroid Plexus: Related to Race and Hippocampus Signal. (2018) (58)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Memory self-awareness in the preclinical and prodromal stages of Alzheimer’s disease (2017) (56)
- Biomarker validation of a decline in semantic processing in preclinical Alzheimer's disease. (2016) (54)
- Accelerated decline in white matter integrity in clinically normal individuals at risk for Alzheimer's disease (2016) (54)
- Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex (2017) (53)
- Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive Impairment. (2015) (53)
- Apathy is associated with increased amyloid burden in mild cognitive impairment. (2013) (53)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Aβ Imaging: feasible, pertinent, and vital to progress in Alzheimer’s disease (2012) (52)
- Free and cued memory in relation to biomarker-defined abnormalities in clinically normal older adults and those at risk for Alzheimer’s disease (2015) (52)
- Vascular Disease and Risk Factors are Associated With Cognitive Decline in the Alzheimer Disease Spectrum (2015) (51)
- Estimating Total Cerebral Microinfarct Burden From Diffusion-Weighted Imaging (2015) (50)
- Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid (2019) (50)
- Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. (2017) (49)
- Graph Convolutional Neural Networks For Alzheimer’s Disease Classification (2019) (49)
- Amyloid-associated increases in longitudinal report of subjective cognitive complaints (2018) (49)
- Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images (2018) (49)
- In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline (2021) (48)
- Neuropsychiatric Symptoms and Functional Connectivity in Mild Cognitive Impairment. (2015) (47)
- Apathy is associated with lower inferior temporal cortical thickness in mild cognitive impairment and normal elderly individuals. (2015) (47)
- Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum. (2014) (46)
- Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group (2016) (46)
- Cognitive resilience in clinical and preclinical Alzheimer’s disease: the Association of Amyloid and Tau Burden on cognitive performance (2017) (45)
- Hippocampal hypometabolism in older adults with memory complaints and increased amyloid burden (2017) (45)
- Network assemblies in the functional brain. (2012) (45)
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. (2022) (44)
- Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD (2019) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- Cerebral perfusion imaging in Alzheimer??s disease: use of single photon emission computed tomography and iofetamine hydrochloride I 123 (1987) (44)
- Dedifferentiation of caudate functional connectivity and striatal dopamine transporter density predict memory change in normal aging (2018) (44)
- PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies (2015) (43)
- The ups and downs of the posteromedial cortex: age- and amyloid-related functional alterations of the encoding/retrieval flip in cognitively normal older adults. (2013) (43)
- Instrumental Activities of Daily Living Impairment Is Associated with Increased Amyloid Burden (2011) (42)
- PET imaging of tau protein targets: a methodology perspective (2019) (41)
- Cued memory decline in biomarker-defined preclinical Alzheimer disease (2017) (40)
- Lower Late-Life Body-Mass Index is Associated with Higher Cortical Amyloid Burden in Clinically Normal Elderly. (2016) (39)
- In vivo rate-determining steps of tau seed accumulation in Alzheimer’s disease (2021) (39)
- Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults. (2019) (38)
- Global White Matter Diffusion Characteristics Predict Longitudinal Cognitive Change Independently of Amyloid Status in Clinically Normal Older Adults (2019) (37)
- Microfluidic continuous-flow radiosynthesis of [18F]FPEB suitable for human PET imaging. (2014) (37)
- Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment. (2014) (37)
- A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease (2016) (37)
- Matched signal detection on graphs: Theory and application to brain imaging data classification (2016) (36)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- Regional tau pathology and loneliness in cognitively normal older adults (2018) (34)
- Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease. (2017) (34)
- Cognitive activity relates to cognitive performance but not to Alzheimer disease biomarkers (2015) (33)
- Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly (2016) (33)
- A Spectral Graph Regression Model for Learning Brain Connectivity of Alzheimer’s Disease (2015) (33)
- Neuroimaging markers associated with maintenance of optimal memory performance in late-life (2017) (33)
- Association of anxiety with subcortical amyloidosis in cognitively normal older adults (2018) (32)
- Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment. (2020) (31)
- Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline (2020) (31)
- Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria (2016) (31)
- Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum. (2014) (31)
- Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. (2020) (30)
- Partial volume correction for PET quantification and its impact on brain network in Alzheimer’s disease (2017) (29)
- Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11C altropane positron emission tomography study (2014) (28)
- Genetic studies of plasma analytes identify novel potential biomarkers for several complex traits (2016) (28)
- Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study (2021) (28)
- Plasma N-terminal tau fragment levels predict future cognitive decline and neurodegeneration in healthy elderly individuals (2020) (28)
- Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation (2020) (27)
- Modulation of TREM2 by CD33: a protein QTL study integrates Alzheimer loci in human monocytes (2015) (27)
- Trans-pQTL study identifies immune crosstalk between Parkinson and Alzheimer loci (2016) (25)
- Dementia: new criteria but no new treatments (2012) (24)
- National Electrical Manufacturers Association and Clinical Evaluation of a Novel Brain PET/CT Scanner (2016) (24)
- SPECT Perfusion Imaging in the Diagnosis of Dementia (1995) (23)
- [18F]-AV-1451 binding profile in chronic traumatic encephalopathy: a postmortem case series (2019) (23)
- Association of Digital Clock Drawing With PET Amyloid and Tau Pathology in Normal Older Adults (2021) (22)
- Linear regression with a randomly censored covariate: application to an Alzheimer's study (2017) (21)
- Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia. (2019) (21)
- Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively unimpaired older adults (2021) (21)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- PET Image Deblurring and Super-Resolution With an MR-Based Joint Entropy Prior (2019) (21)
- Decreased hippocampal metabolism in high-amyloid mild cognitive impairment (2016) (20)
- Intelligence quotient–adjusted memory impairment is associated with abnormal single photon emission computed tomography perfusion (2007) (20)
- Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults (2020) (20)
- Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease (2019) (20)
- Evaluation of pharmacokinetic modeling strategies for in-vivo quantification of tau with the radiotracer [18F]MK6240 in human subjects (2019) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults (2020) (19)
- Identifying Sensitive Measures of Cognitive Decline at Different Clinical Stages of Alzheimer’s Disease (2020) (19)
- Dopamine transporter availability in clinically normal aging is associated with individual differences in white matter integrity (2016) (19)
- Current directions in tau research: Highlights from Tau 2020 (2021) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease (2020) (18)
- Amyloid imaging of dutch‐type hereditary cerebral amyloid angiopathy carriers (2019) (17)
- Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease (2019) (17)
- Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study (2022) (17)
- Multimodal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury. (2019) (17)
- Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy (2019) (16)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Quantitative SPECT leads to improved performance in discrimination tasks related to prodromal Alzheimer's disease. (2004) (16)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- Amyloid imaging of alzheimer’s disease using pittsburgh compound B (2006) (16)
- Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease (2019) (16)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Lower novelty-related locus coeruleus function is associated with Aβ-related cognitive decline in clinically healthy individuals (2022) (15)
- Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease (2020) (15)
- Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease (2020) (15)
- The Harvard Automated Phone Task: new performance-based activities of daily living tests for early Alzheimer's disease. (2015) (14)
- Right lateral prefrontal cortex—specificity for inhibition or strategy use? (2015) (14)
- Resting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer’s disease (2020) (14)
- Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer’s Disease: A Case Series (2021) (14)
- Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study (2019) (14)
- Longitudinal degradation of the default/salience network axis in symptomatic individuals with elevated amyloid burden. (2019) (13)
- Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease (2021) (13)
- Handbook of institutional investment and fiduciary duty (2014) (13)
- Impaired memory is more closely associated with brain beta-amyloid than leukoaraiosis in hypertensive patients with cognitive symptoms (2018) (13)
- The influence of demographic factors on subjective cognitive concerns and beta-amyloid (2016) (13)
- Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study. (2020) (13)
- Multi-Modal Signatures of Tau Pathology, Neuronal Fiber Integrity, and Functional Connectivity in Traumatic Brain Injury (2019) (13)
- Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults (2020) (13)
- The AHEAD 3–45 Study: Design of a prevention trial for Alzheimer’s disease (2022) (13)
- Synergism between fornix microstructure and beta amyloid accelerates memory decline in clinically normal older adults (2019) (13)
- Pro: Can biomarkers be gold standards in Alzheimer's disease? (2010) (13)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults (2017) (12)
- Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. (2022) (12)
- You don't say: dynamic aphasia, another variant of primary progressive aphasia? (2013) (11)
- Nonlinear Distributional Mapping (NoDiM) for harmonization across amyloid-PET radiotracers (2019) (11)
- Word retrieval across the biomarker-confirmed Alzheimer's disease syndromic spectrum (2020) (11)
- The presubiculum links incipient amyloid and tau pathology to memory function in older persons (2020) (11)
- Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease (2022) (11)
- 18F-AV-1451 positron emission tomography in neuropathological substrates of corticobasal syndrome. (2020) (10)
- Does hippocampal FDG-PET asymmetry predict verbal memory dysfunction after left temporal lobectomy? (2009) (10)
- THE A4 TRIAL: ANTI-AMYLOID TREATMENT OF ASYMPTOMATIC ALZHEIMER'S DISEASE (2012) (10)
- Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture. (2018) (10)
- Topography of cortical thinning in the Lewy body diseases (2020) (10)
- Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring (2016) (10)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- A Longitudinal Model for Tau Aggregation in Alzheimer's Disease Based on Structural Connectivity (2019) (9)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- Functional Connectivity in Alzheimer’s Disease: Measurement and Meaning (2013) (9)
- IMAGING TAU PATHOLOGY IN VIVO IN FTLD: INITIAL EXPERIENCE WITH [18F] T807 PET (2014) (9)
- The Centiloid Scale: Standardization of amyloid imaging measures (2013) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Attenuation Correction Using Deep Learning and Integrated UTE/Multi-Echo Dixon Sequence: Evaluation in Amyloid and Tau PET Imaging (2020) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Multiple imputation of a randomly censored covariate improves logistic regression analysis (2016) (8)
- Cambridge Handbook of Institutional Investment and Fiduciary Duty: Challenging conventional wisdom on fiduciary duty (2015) (8)
- Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease (2021) (8)
- Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum (2020) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer’s disease (2021) (8)
- AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial) (2020) (8)
- Activities of daily living measured by the Harvard Automated Phone Task track with cognitive decline over time in non-demented elderly. (2017) (8)
- Structural tract alterations predict downstream tau accumulation in amyloid-positive older individuals (2018) (7)
- Association of Memory Impairment With Concomitant Tau Pathology in Patients With Cerebral Amyloid Angiopathy (2021) (7)
- SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment. (2014) (7)
- Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals (2017) (7)
- Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study (2020) (7)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- Threshold regression to accommodate a censored covariate (2018) (7)
- Massachusetts Alzheimer's Disease Research Center: Progress and challenges (2015) (7)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- Association of Midlife Depressive Symptoms with Regional Amyloid-β and Tau in the Framingham Heart Study. (2021) (7)
- To sleep, perchance to delay dementia. (2012) (7)
- Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group (2016) (6)
- Functional and Pathological Correlates of Judgments of Learning in Cognitively Unimpaired Older Adults. (2019) (6)
- Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study (2022) (6)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- Decreased meta-memory is associated with early tauopathy in cognitively unimpaired older adults (2019) (6)
- IMAGING TAU PATHOLOGY IN VIVO IN FTLD: INITIAL EXPERIENCE WITH [18F] T807 PET (2014) (6)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments (2019) (6)
- Multiple markers contribute to risk of progression from normal to mild cognitive impairment (2020) (6)
- TAU PET USING F18-T807: INITIAL EXPERIENCE IN NORMAL ELDERLY AND AD DEMENTIA (2014) (6)
- MR-Based PET Attenuation Correction using a Combined Ultrashort Echo Time/Multi-Echo Dixon Acquisition. (2020) (6)
- Comparing PET and MRI Biomarkers Predicting Cognitive Decline in Preclinical Alzheimer Disease (2021) (5)
- GREATER SUBJECTIVE COGNITIVE CONCERNS CORRESPOND WITH ADVANCING STAGES OF PRECLINICAL AD (2014) (5)
- The Neuropsychology of Preclinical Alzheimer’s Disease: Differential Sensitivity of Component Processes of Memory Performance on Biomarker Evidence of Amyloidosis (S41.004) (2015) (5)
- Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non‐demented individuals with autosomal‐dominant Alzheimer's disease (2021) (5)
- Reply: Beyond the limits of detection: Failure of PiB imaging to capture true Aβ burden (2013) (5)
- Regional cortical thinning predicts worsening apathy and hallucinations in mild cognitive impairment and mild Alzheimer's disease (2012) (5)
- Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer’s disease (2019) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- The neurophysiology and seizure outcomes of late onset unexplained epilepsy (2020) (5)
- Subjective cognitive concerns, amyloid burden and cognitive reserve (2013) (5)
- Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study. (2022) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease (2022) (5)
- PET imaging of β-amyloid with florpiramine F18 (18F-AV-45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease (2009) (4)
- Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults. (2022) (4)
- Effect of vascular amyloid on white matter disease is mediated by vascular dysfunction in cerebral amyloid angiopathy (2022) (4)
- Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study (2009) (4)
- Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly (2015) (4)
- Challenging tests of memory are more sensitive to detect effects of amyloid deposition in normal elderly subjects (2009) (4)
- Association of Emerging β-Amyloid and Tau Pathology With Early Cognitive Changes in Clinically Normal Older Adults (2022) (4)
- Regional cortical thinning predicts worsening apathy and hallucinations in mild cognitive impairment and mild Alzheimer's disease dementia (2012) (4)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Longitudinal predictive modeling of tau progression along the structural connectome (2021) (4)
- Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia. (2022) (4)
- TAU AND AB DEPOSITS RELATE TO DISTINCTIVE FUNCTIONAL CONNECTIVITY DISRUPTIONS IN THE ELDERLY BRAIN (2014) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease (2020) (4)
- Florbetapir F 18 (18F-AV-45) PET amyloid imaging predicts progression of cognitive impairment: A longitudinal clinical follow up study (2010) (3)
- Instrumental activities of daily living and functional connectivity in mild cognitive impairment (2015) (3)
- A NEW PERFORMANCE-BASED ACTIVITIES OF DAILY LIVING INSTRUMENT FOR EARLY ALZHEIMER'S DISEASE (2014) (3)
- Functional Imaging in Alzheimer’s Disease (2000) (3)
- TAU PET IN A4: PRELIMINARY REPORT (2018) (3)
- LONGITUDINAL TAU ACCUMULATION IS ASSOCIATED WITH COGNITIVE DECLINE IN NORMAL ELDERLY (2017) (3)
- Striatal and Extrastriatal Dopamine Transporter Levels Relate to Cognition in Lewy Body Diseases (P2.009) (2014) (3)
- Decreased resting state functional connectivity at baseline predicts subjective memory complaints after 1 year in cognitively normal individuals and individuals with mild cognitive impairment (2013) (3)
- Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment (2022) (3)
- Associative memory and in vivo brain pathology in asymptomatic presenilin-1 E280A carriers (2020) (3)
- Correction: Association of anxiety with subcortical amyloidosis in cognitively normal older adults (2018) (3)
- Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI (2022) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- Epicenters of dynamic connectivity in the adaptation of the ventral visual system (2017) (3)
- THE ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMER'S DISEASE (A4) STUDY: REPORT OF SCREENING DATA RESULTS (2018) (3)
- High resolution PET imaging of tau using an MR-based information theoretic anatomical prior (2014) (3)
- Cognitive resilience in clinical and preclinical Alzheimer’s disease: the Association of Amyloid and Tau Burden on cognitive performance (2016) (3)
- Longitudinal Trajectories of Participant- and Study Partner-Rated Cognitive Decline, in Relation to Alzheimer’s Disease Biomarkers and Mood Symptoms (2022) (3)
- Network Tau spreading is vulnerable to the expression gradients of APOE and glutamatergic-related genes (2022) (3)
- Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults (2021) (3)
- Increased amyloid deposition is related to failure of habituation of the default network but preserved repetition suppression in the hippocampus during successful repetition encoding in cognitively normal older adults (2010) (3)
- GERIATRIC DEPRESSION SCALE ITEM-LEVEL ANALYSIS IN RELATION TO IN VIVO CORTICAL AMYLOID AND CEREBRAL REGIONAL TAU IN CLINICALLY NORMAL OLDER ADULTS: FINDINGS FROM THE HARVARD AGING BRAIN STUDY (2019) (3)
- Cambridge Handbook of Institutional Investment and Fiduciary Duty: Introduction (2014) (3)
- Hippocampal metabolism is decreased in high-amyloid mild cognitive impairment but not in high-amyloid clinically normal elders (2015) (2)
- IC-103-04 Amyloid burden correlates with cognitive function in normal aging, MCI and AD (2006) (2)
- Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system (2021) (2)
- SIST-M-IR activities of daily living items that best discriminate the clinically normal elderly from those with mild cognitive impairment (2013) (2)
- An UNC5C Allele Predicts Cognitive Decline and Hippocampal Atrophy in Clinically Normal Older Adults. (2019) (2)
- Alzheimer’s disease biomarker roadmap 2020: Second‐generation tau PET tracers (2020) (2)
- Pharmacokinetic evaluation of the tau radiotracer [18F]T807 and cerebral binding in a subject with traumatic brain injury (2014) (2)
- Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players (2022) (2)
- Amyloid deposition in non-demented elderly predicts longitudinal cognitive decline (2011) (2)
- Sex, tau, and cortical thinning in the temporal lobe: Findings from the Harvard Aging Brain Study (2020) (2)
- Elevated PiB precedes dementia in autosomal dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort (2012) (2)
- AMYLOID-B DEPOSITION IN MILD COGNITIVE IMPAIRMENT IS ASSOCIATED WITH HIPPOCAMPAL HYPERACTIVATION, ATROPHY, AND CLINICAL PROGRESSION (2014) (2)
- Hypoconnectivity between locus coeruleus and medial temporal lobe during novelty predicts accelerated Aβ‐related cognitive decline (2020) (2)
- O4-06-06 Combined dopamine transporter and FDG pet in DLB, AD, and PD (2004) (2)
- Prognostic significance of florbetapir F18 PET imaging in MCI and mormal elderly: Final results from a longitudinal multicenter trial (2011) (2)
- TAU ACCUMULATION IN CLINICALLY NORMAL OLDER ADULTS IS ASSOCIATED WITH INCREASES IN HIPPOCAMPAL FMRI ACTIVITY (2017) (2)
- Grip strength and gait speed as early biomarkers of brain amyloid and tau deposition (2020) (2)
- LONGITUDINAL CHANGE OF FUNCTIONAL CONNECTIVITY IN PRECLINICAL AD: RESULTS FROM THE HARVARD AGING BRAIN STUDY (2018) (2)
- A Physics-Informed Geometric Learning Model for Pathological Tau Spread in Alzheimer's Disease (2020) (2)
- Patterns of Dementia in Alzheimer's Disease—Reply (1992) (2)
- THE EFFECT OF TRACT-SPECIFIC LOSS OF WHITE MATTER CONNECTIVITY ON COGNITIVE DECLINE IN HEALTHY OLDER INDIVIDUALS DEPENDS ON ENTORHINAL T807 BINDING (2016) (2)
- LOCUS COERULEUS SIGNAL INTENSITY IS ASSOCIATED WITH ENTORHINAL TAU PATHOLOGY AT HIGHER LEVELS OF AMYLOID BURDEN (2018) (2)
- LONGITUDINAL TAU ACCUMULATION IS ASSOCIATED WITH COGNITIVE DECLINE IN NORMAL ELDERLY (2017) (2)
- Kinetic evaluation and assessment of longitudinal changes in reference region and extracerebral [18F]MK-6240 PET uptake (2022) (2)
- Increased cerebral blood flow in cognitively normal older adults with amyloid (2013) (2)
- Harmonizing the preclinical Alzheimer cognitive composite for multi‐cohort studies (2020) (2)
- IN VIVO CORTICAL DISTRIBUTION OF TAU AND AMYLOID DEPOSITS IN COGNITIVELY NORMAL ELDERLY (2016) (2)
- Amyloid imaging of cerebral amyloid angiopathy (2007) (1)
- Microbleeds, amyloid-beta burden and FDG metabolism in non-demented elderly (2011) (1)
- DETECTING COGNITIVE PROFILES IN THE BIOMARKER STAGES OF PRECLINICAL AD (2014) (1)
- 0300 Linking Sleep Disturbances with Amyloid and Tau Imaging. Preliminary Findings from the Harvard Aging Brain Study (2019) (1)
- Extraneous neuroimaging factors do not contribute to sex differences in flortaucipir signal: Analysis of skull binding and partial volume effects (2021) (1)
- PROTECTIVE EFFECT OF PHYSICAL ACTIVITY ON LONGITUDINAL COGNITIVE DECLINE AND NEURODEGENERATION IN CLINICALLY NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID BURDEN (2019) (1)
- Disclosure of amyloid status in the a4 trial (2015) (1)
- Low CSF Abeta 1-42 is associated with worsening daily functioning in mild cognitive impairment and mild Alzheimer's disease (2011) (1)
- Amplification, not spreading limits rate of tau aggregate accumulation in Alzheimer’s disease (2020) (1)
- THE HARVARD AUTOMATED PHONE TASK (APT): A NOVEL PERFORMANCE-BASED ADL INSTRUMENT FOR EARLY ALZHEIMER’S DISEASE (2016) (1)
- Blood phosphorylated tau 181 predicts early, preclinical brain amyloid deposition (2021) (1)
- Microstructural White Matter Alterations Correlate with Cerebral Amyloid Angiopathy Burden and Cognitive Measures: A DTI/PET Study (P6.313) (2014) (1)
- CERTAIN PLASMA N-TERMINAL TAU FRAGMENTS ARE ELEVATED IN AD AND AD-MCI COMPARED TO CONTROLS (2018) (1)
- LOCUS COERULEUS INTENSITY IS ASSOCIATED WITH EARLY AMYLOID AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2019) (1)
- The relationship of cognition, cognitive reserve, and in vivo tau and amyloid burden (2015) (1)
- Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD (2021) (1)
- Longitudinal 18F-T807 PET imaging in a case of nonfluent variant primary progressive aphasia (2015) (1)
- Association of tau tangle burden with depressive symptoms in community‐dwelling older adults: A longitudinal study (2020) (1)
- NEUROIMAGING CORRELATES OF ANOSOGNOSIA IN MILD COGNITIVE IMPAIRMENT (2016) (1)
- IC-P-016 Imaging of cerebral amyloid angiopathy with Pittsburgh compound B (2006) (1)
- Relationship of Florbetapir F18 PET Amyloid Plaque Neuroimaging with Future Cognitive Decline over 36 Months (2013) (1)
- Successful memory retrieval requires increased parietal activity in asymptomatic older adults with high amyloid burden (2009) (1)
- Disrupted functional connectivity in autosomal dominant Alzheimer's disease: Preliminary findings from the DIAN study (2012) (1)
- IC-P2-077: Amyloid deposition related to cortical thinning (2008) (1)
- Progressive white matter abnormalities in autosomal dominant Alzheimer's disease: Results of the DIAN study (2012) (1)
- CAPTURING COGNITIVE IMPAIRMENT AT THE PRECLINICAL STAGE OF ALZHEIMER’S DISEASE USING DIGITAL TECHNOLOGY (2019) (1)
- AB+ CLINICALLY NORMAL PARTICIPANTS WITH ELEVATED TAU SHOW GREATEST DECLINE IN THE PRECLINICAL ALZHEIMER’S DISEASE COGNITIVE COMPOSITE (2016) (1)
- Cortical thickness across the lifespan in a Colombian cohort with autosomal‐dominant Alzheimer's disease: A cross‐sectional study (2021) (1)
- White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantlyinherited Alzheimer’s disease (2018) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- AMYLOID-β DEPOSITION IN MILD COGNITIVE IMPAIRMENT IS ASSOCIATED WITH HIPPOCAMPAL HYPERACTIVATION, ATROPHY, AND CLINICAL PROGRESSION (2014) (1)
- Amyloid deposition and instrumental activities of daily living impairment in non-demented elderly (2009) (1)
- Progressive White Matter Injury in Preclinical Dutch Cerebral Amyloid Angiopathy (2022) (1)
- Associations between remote cognitive testing on an individual’s own digital device and amyloid burden on neuroimaging in clinically normal older adults: Results from Boston Remote Assessment for Neurocognitive Health (BRANCH) (2021) (1)
- Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively normal older adults (2020) (1)
- TAU AND HIPPOCAMPAL VOLUME REFLECT DISTINCT PROCESSES IN PRECLINICAL ALZHEIMER’S DISEASE (2017) (1)
- Detecting cognitive evidence of preclinical Alzheimer's disease (2013) (1)
- PET STAGING OF AMYLOIDOSIS: EVIDENCE THAT AMYLOID OCCURS FIRST IN NEOCORTEX AND LATER IN STRIATUM (2016) (1)
- Regional Tau PET measures associated with memory performance in clinically normal older individuals (2015) (1)
- REGIONAL ASYMMETRIES IN AMYLOID AND TAU GO TOGETHER: EVIDENCE FOR LOCAL INTERACTION (2018) (1)
- Structural, Functional, and Molecular Neuroimaging Biomarkers for Alzheimer’s Disease (2013) (1)
- SPATIAL PATTERNS OF FLORTAUCIPIR (FTP) SIGNAL IN COGNITIVELY NORMAL ELDERLY (2017) (1)
- AHEAD 3‐45 study: Preliminary screening and baseline characteristics from a placebo‐controlled, double‐blind study evaluating lecanemab in participants with preclinical Alzheimer’s disease and elevated (A45 trial) and intermediate (A3 trial) amyloid (2021) (1)
- QRISK2 AND FRAMINGHAM CARDIOVASCULAR RISK SCORES SIGNIFICANTLY CORRELATE WITH IMAGING BIOMARKERS OF PRECLINICAL AD: FINDINGS FROM THE HARVARD AGING BRAIN STUDY (2017) (1)
- Amyloid deposition and cortical thickness in aging and Alzheimer's disease (2008) (1)
- Alzheimer’s disease biomarker roadmap 2020: Time for tau (2020) (1)
- Locus coeruleus integrity predicts tau accumulation and memory dysfunction in autosomal dominant Alzheimer’s disease (2021) (1)
- P1-295: Longitudinal functional MRI demonstrates loss of hippocampal activation associated with clinical decline in nondemented older subjects (2008) (1)
- Neurobiological correlates of anosognosia in mild cognitive impairment: A multi-modal investigation using FDG-PET, PiB-PET, and volumetric MRI (2015) (1)
- GENOTYPIC VARIANCE MAY EXPLAIN THE BALANCE OF EARLY CORTICAL VERSUS STRIATAL AMYLOID DEPOSITION IN AUTOSOMAL DOMINANT AD (2017) (1)
- Cognitive reserve modifies the relationship of neuropsychological performance and amyloid deposition in normal elderly subjects (2009) (1)
- Face Name Associative Memory Exam (2019) (1)
- Short-term predictors of clinical progression in the Harvard Aging Brain Study (2013) (1)
- Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an 11C altropane positron emission tomography study (2014) (1)
- High-Resolution Structural Brainstem Nuclei: Locus Coeruleus Integrity as Potential Biomarker of Alzheimer’s Disease-Related Phenotypes (2022) (1)
- Spect Imaging In Alzheimer's Disease. B. Leanard Holman, Brigham And Women's Hospital (1988) (1)
- Amyloid hubs in individual PiB-PET imaging (2013) (1)
- DIGITIZED CLOCK DRAWING (DCTCLOCKTM) PERFORMANCE AND ITS RELATIONSHIP TO AMYLOID AND TAU PET IMAGING MARKERS IN UNIMPAIRED OLDER ADULTS (2018) (1)
- THE ASSOCIATION BETWEEN INSTRUMENTAL ACTIVITIES OF DAILY LIVING AND CORTICAL AMYLOID IN COGNITIVELY NORMAL OLDER ADULTS SCREENING FOR THE A4 STUDY (2019) (1)
- PET image denoising based on denoising diffusion probabilistic models (2022) (1)
- Amyloid deposition and instrumental activities of daily living impairment in nondemented elderly (2009) (1)
- Short-term predictors of clinical progression in the Harvard Aging Brain Study (2013) (1)
- Preclinical Prediction of AD: Relation Between Neuropsychological and Neuroimaging Findings (2002) (1)
- Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease. (2022) (1)
- Changes in cerebral glucose metabolism and functional whole brain connectivity in relation to {beta}-amyloid load in pre-dementia stages of Alzheimer's disease (2010) (0)
- AV1451 TAU PET, BUT NOT CSF TAU, IS RELATED TO MEMORY DECLINE IN PRECLINICAL AND PRODROMAL ALZHEIMER'S DISEASE (2018) (0)
- LOCUS COERULEUS HYPERMETABOLISM IS ASSOCIATED WITH AMYLOID-RELATED MEDIAL TEMPORAL TAU PATHOLOGY (2019) (0)
- QUANTIFYING STAGES OF SUBTLE MEMORY IMPAIRMENT IN PRECLINICAL ALZHEIMER’S DISEASE (2018) (0)
- Podium Presentations: Wednesday, July 25, 2018 P1394 F4-07-04 THE CONSEQUENCES OF TAU IN THE LOCUS COERULEUS ON ALZHEIMER’S DISEASE (2018) (0)
- Prognostic significance of Florbetapir (18F-Florbetapir) PET imaging for future cognitive performance in recently diagnosed MCI: Final results from a 3-year multicenter longitudinal trial (2012) (0)
- Tau positron emission tomography in preclinical Alzheimer's disease. (2022) (0)
- Abstract 48: Cerebral Amyloid Angiopathy in Asymptomatic Community-Dwelling Older Adults (2016) (0)
- Time scales for time-to-event analyses of Alzheimer's studies (2011) (0)
- AMYLOID IS ASSOCIATED WITH GREATER TAU BURDEN IN CLINICALLY NORMAL FEMALES RELATIVE TO MALES: FINDINGS FROM TWO INDEPENDENT COHORTS (2018) (0)
- TOPOGRAPHY OF CORTICAL THINNING IN THE LEWY BODY DEMENTIAS (2019) (0)
- TAU BURDEN IS ASSOCIATED WITH SUBJECTIVE COGNITIVE CONCERNS IN THE CONTEXT OF β-AMYLOID BURDEN IN PRECLINICAL AD (2016) (0)
- IC-P-206 QUANTITATIVE SCORING OF [18F] FLORTAUCIPIR PET SCANS IN TYPICAL AND ATYPICAL PHENOTYPES OF ALZHEIMER’S DISEASE THE ABILITY OF ATAU SPATIAL SPREAD METRIC TO INDICATE DISEASE PROGRESSION COMPARED TO AN INTENSITY-BASED APPROACH (2018) (0)
- Investigating the Association between Depressive Symptoms and Cortical Tau Across the Alzheimer's Disease Spectrum (2016) (0)
- Specific hippocampal subfield volumes mediate tau-related memory performance in amyloid-positive individuals (2016) (0)
- Optimizing early detection of beta‐amyloid accumulation with PET using spatial extent (2022) (0)
- Tau PET in aging and AD (2016) (0)
- LONGITUDINAL PEFORMANCE ON THE PRECLINICAL ALZHEIMER’S COGNITIVE COMPOSITE (PACC) IN SUBJECTS WITH BIOMARKER-DEFINED PRECLINCAL AD (2016) (0)
- P2.213 Ab amyloid deposits are common in brains of non-demented PD patients (2009) (0)
- Abstract 2891: Severity of Amyloid Deposition is Associated with Ischemic White Matter Disease in Cerebral Amyloid Angiopathy but Not in Healthy Elderly: a PET/MRI Correlative Study (2012) (0)
- Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease (2023) (0)
- Elevated tau‐PET signal predicts near‐term conversion to mild cognitive impairment in cognitively unimpaired older adults (2022) (0)
- TEMPORAL NEOCORTICAL TAU DEPOSITION MEASURED WITH PET IS ASSOCIATED WITH LONGITUDINAL DECLINE IN MEMORY PERFORMANCE AMONG CLINICALLY NORMAL ELDERLY (2014) (0)
- ITEM-LEVEL COMPARISON OF PARTICIPANT AND STUDY PARTNER REPORT ON THE COGNITIVE FUNCTION INDEX BY AMYLOID PET FROM THE A4 STUDY (2019) (0)
- ASSOCIATIONS OF REGIONAL CORTICAL THINNING AND LONGITUDINAL COGNITIVE PERFORMANCE IN THE CONTEXT OF AMYLOID IN CLINICALLY NORMAL OLDER ADULTS (2019) (0)
- Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study. (2022) (0)
- Longitudinal associations between amyloid and tau‐PET: Impact for prevention trials (2021) (0)
- IMPACT OF DISCLOSING AMYLOID IMAGING RESULTS TO COGNITIVELY NORMAL RESEARCH PARTICIPANTS: THE A4 EXPERIENCE (2018) (0)
- Longitudinal tau burden partially mediates synergistic influence of vascular risk and amyloid‐beta on cognitive decline in clinically normal older adults (2022) (0)
- Entorhinal, parahippocampal, and inferior temporal F18-T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly (2015) (0)
- SEVERITY OF SUBJECTIVE COGNITIVE DECLINE ALIGNS WITH REGIONAL AMYLOID SEVERITY: FINDINGS FROM THE HARVARD AGING BRAIN STUDY (2017) (0)
- TAU ACCUMULATION IN RHINAL CORTEX IS ASSOCIATED WITH MEMORY PERFORMANCE IN NON-DEMENTED YOUNG ADULTS WITH AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE (2018) (0)
- Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study (2012) (0)
- Physical activity is associated with increased resting‐state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults (2022) (0)
- Clinical and neuroimaging predictors of psychological well-being as measured by the purpose in life scale in cognitively normal older individuals (2015) (0)
- ASSOCIATIONS BETWEEN AMYLOIDOSIS AND LONGITUDINAL COGNITIVE DECLINE IN CLINICALLY NORMAL OLDER ADULTS (2016) (0)
- Decreased lodine-123 IMP Caudate Nucleus Uptake in Patients with Huntington's Disease (1988) (0)
- Brain and hippocampal rates of atrophy in familial Alzheimer's disease mutation carriers: Preliminary findings from the DIAN study (2012) (0)
- IC-P-214 HIGH RED MEAT INTAKE IS ASSOCIATED WITH INCREASED TAU ON [F] FLORTAUCIPIR PETAND POORER MEMORY (2018) (0)
- Heterogeneity of tau deposition and microvascular involvement in MCI and AD (2021) (0)
- Cognitive reserve mediates amyloid-related cognitive impairment (2008) (0)
- TAU ACCUMULATION IN THE ENTORHINAL CORTEX AND PRECUNEUS IS ASSOCIATED WITH CORTICAL AMYLOID-BETA BURDEN, AGE AND WORSE MEMORY PERFORMANCE IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE (2018) (0)
- ASSOCIATIONS BETWEEN MEASURES OF MEDIAL TEMPORAL LOBE NEURODEGENERATION AND ANOSOGNOSIA FOR MEMORY DEFICITS (2017) (0)
- A longitudinal analysis of depressive symptoms in relation to repeated measurements of regional tau (2022) (0)
- Instrumental activities of daily living and functional connectivity in mild cognitive impairment (2015) (0)
- Imaging tau Pathology In Vivo in AD and FTLD Spectrum Tauopathies with [18F] AV1451 PET (P4.010) (2016) (0)
- Depressive symptoms are associated with hippocampal neurodegeneration in preclinical autosomal dominant Alzheimer’s disease (2020) (0)
- Snap in cognitively normal adults (2015) (0)
- Vascular health is associated with locus coeruleus‐related entorhinal tau deposition (2022) (0)
- A Novel Penalized Joint Image Reconstruction Method for Tau-PET Imaging (2018) (0)
- Amyloid Burden in Late MCI Subjects Related to Failure of Hippocampal Activation (2010) (0)
- SEX DIFFERENCES IN TAU PATHOLOGY ACROSS CORTICAL AND SUBCORTICAL REGIONS OF INTEREST: FINDINGS ACROSS TWO COHORTS (2019) (0)
- Characterizing biomarker dynamics along the Alzheimer's disease trajectory (2011) (0)
- Progressive white matter injury in autosomal dominant Alzheimer’s disease is strongly associated with cerebral microbleeds and neurodegeneration (2022) (0)
- disease without dementia Amyloid is linked to cognitive decline in patients with Parkinson (0)
- Dissociations between entorhinal and hippocampal activity in cognitively normal older adults with and without beta-amyloid deposition (2013) (0)
- Multimodal genome‐wide meta‐analysis of brain amyloidosis reveals heterogeneity across CSF, PET, and pathological amyloid measures (2020) (0)
- LONGITUDINAL DEPRESSIVE SYMPTOMS AND CORTICAL AMYLOID ARE ASSOCIATED WITH COGNITIVE DECLINE IN OLDER ADULTS (2018) (0)
- Hippocampal Volume and Cardiovascular Risk Using the QRISK2 Prediction Tool in Cognitively Normal Elderly (2015) (0)
- Vascular risk factors are associated with cognitive decline in mild cognitive impairment (2011) (0)
- Tau deposition and white matter fiber integrity in traumatic brain injury: an [18F]T807 PET and diffusion tensor imaging study (2015) (0)
- The role of cortical microstructural changes on longitudinal accumulation of tau and cognitive decline in at risk older adults (2022) (0)
- Reclaiming pension fund fiduciary duty fundamentals (2015) (0)
- Amyloid imaging with PIB associated with impaired memory function on fMRI (2007) (0)
- EVOLUTION AND PATHOLOGICAL BASIS OF ALTERED MEMORY SELF-AWARENESS IN COGNITIVELY NORMAL OLDER ADULTS (2019) (0)
- Neuropsychiatric Symptoms are Associated with Current and Future Global Functional Impairment in Mild Cognitive Impairment (2011) (0)
- PROFILES OF COGNITIVE DECLINE ASSOCIATED WITH BIOMARKER-DEFINED PRECLINICAL STAGES OF ALZHEIMER’S DISEASE (2016) (0)
- COVARYING SPATIAL PATTERNS OF TAU DEPOSITION AND GRAY MATTER ATROPHY UNEARTHED BY THE INFORMED MULTIMODAL PARTIAL LEAST SQUARES (MMPLS) IN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: FINDINGS FROM THE COLBOS PROJECT (2019) (0)
- P2-268 Amyloid deposition in presymptomatic familial Alzheimer’s disease (2006) (0)
- Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states (2018) (0)
- SEMANTIC MEMORY AND PET AMYLOID AND TAU DEPOSITION IN PRECLINICAL AND PRODROMAL ALZHEIMER’S DISEASE (2017) (0)
- What Does MRI Study of Cognitive Loss and Brain Loss Tell Us (2005) (0)
- GREATER SUBJECTIVE COGNITIVE CONCERNS CORRESPOND WITH ADVANCING STAGES OF PRECLINICAL AD (2014) (0)
- INCREASED TAU PET SIGNAL ASSOCIATED WITH LONGITUDINAL MR ATROPHY IN COGNITIVELY NORMAL OLDER ADULTS (2016) (0)
- Impact of vascular factors and tau deposition on functional brain network connectivity in participants of the Framingham Heart Study (2020) (0)
- Abstract WMP90: Florbetapir PET to Diagnose Cerebral Amyloid Angiopathy (2016) (0)
- LONGITUDINAL DEPRESSIVE SYMPTOMS AND CORTICAL AMYLOID ARE ASSOCIATED WITH COGNITIVE DECLINE IN OLDER ADULTS (2018) (0)
- TAU ACCUMULATION AND MEMORY DECLINE ARE MORE CLOSELY RELATED TO STRIATAL THAN CORTICAL AMYLOIDOSIS IN INDIVIDUALS WITH EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2018) (0)
- ANXIETY, SOCIAL ACTIVITY AND AMYLOID IN COGNITIVELY NORMAL OLDER ADULTS (2016) (0)
- INCREASED TAU PET SIGNAL ASSOCIATED WITH LONGITUDINAL MR ATROPHY IN COGNITIVELY NORMAL OLDER ADULTS (2016) (0)
- Increased cerebral blood flow in cognitively normal older adults with amyloid (2013) (0)
- Tau Mediates Synergistic Influence of Vascular Risk and Aβ on Cognitive Decline (2022) (0)
- Genetic associations with brain amyloidosis (2020) (0)
- Longitudinal increase in depressive symptoms in relation to neurodegeneration in clinically normal older adults: Findings from the Harvard Aging Brain Study (2020) (0)
- Entorhinal tau deposition is associated with parietal association cortex hypometabolism in clinically normal older individuals (2015) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- APOE effects on regional tau in preclinical Alzheimer’s disease (2023) (0)
- 18F‐Flortaucipir PET imaging compared with autopsy in a clinically and pathologically heterogeneous group of patients with neurodegenerative dementias (2021) (0)
- Vascular risk and physical activity as modulators of cognitive and neurodegenerative trajectories: Independent and interactive effects with beta‐amyloid (2020) (0)
- A new flortaucipir PET biomarker based on graph theory for early detection of CTE in former American football players (2022) (0)
- Estimating an individual's placement on a theoretical continuum using longitudinal cognitive trajectories: Relationships with longitudinal amyloid and Tau‐PET (2020) (0)
- Regional FDG metabolism and instrumental activities of daily living across the spectrum of Alzheimer’s disease (2013) (0)
- Microglia‐specific Alzheimer’s disease polygenic risk score is associated with amyloid‐β, tau, and microglial activation (2022) (0)
- Disrupted functional connectivity in autosomal dominant Alzheimer’s disease demonstrates network specificity and precedes brain volume loss: Findings from the Dominantly Inherited Alzheimer Network (2013) (0)
- JOINT DEBLURRING OF LONGITUDINAL DIFFERENTIAL PET IMAGES OF TAU (2018) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- Imaging tau pathology in vivo in FTLD spectrum tauopathies with [18F] T807 PET (I11-5E) (2015) (0)
- Self‐reported history of estrogen hormone therapy differentiates rates of amyloid accumulation (PiB‐PET) relative to males: Findings from the Harvard Aging Brain Study (2021) (0)
- Rate‐limiting processes of tau aggregate accumulation in Alzheimer's disease (2021) (0)
- ANXIETY, SUBJECTIVE COGNITIVE DECLINE, AND CORTICAL AMYLOID IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: A PRELIMINARY REPORT (2017) (0)
- TOPOGRAPHY OF CORTICAL THINNING IN THE LEWY BODY DEMENTIAS (2019) (0)
- SUBSYNDROMAL DEPRESSION AND ALZHEIMER'S DISEASE BIOMARKERS IN COGNITIVELY NORMAL ELDERLY (2014) (0)
- Multimodal neuroimaging biomarkers of Alzheimer’s disease in older adults with depression: Preliminary findings from a pilot cohort (2021) (0)
- Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study (2012) (0)
- Measuring instrumental activities of daily living in non-demented elderly: a comparison of the new performance-based Harvard Automated Phone Task with other functional assessments (2019) (0)
- Neurogenetic contributions to amyloid beta and tau spreading in the human cortex (2018) (0)
- Abstract P442: The Association of Amyloid and Tau Burden With Centrum Semiovale Perivascular Spaces in Cerebral Amyloid Angiopathy (2021) (0)
- Apathy Is Associated with Inferior Temporal Atrophy in Amnestic Mild Cognitive Impairment and Clinically Normal Elderly (P07.149) (2013) (0)
- RELATIONSHIPS BETWEEN MEMORY FUNCTION, TAU PATHOLOGY AND FUNCTIONAL CONNECTIVITY IN THE DEFAULT MODE NETWORK IN AUTOSOMAL-DOMINANT ALZHEIMER’S DISEASE: A PRELIMINARY REPORT (2017) (0)
- Lower novelty‐related locus coeruleus function is associated with entorhinal tau‐mediated memory decline in older individuals. (2022) (0)
- AMYLOID PATHOLOGY EXPLAINS UNAWARENESS OF MEMORY DEFICITS ABOVE AND BEYOND CORTICAL THICKNESS IN INDIVIDUALS WITH MILD COGNITIVE IMPAIRMENT (2018) (0)
- DETECTING COGNITIVE PROFILES IN THE BIOMARKER STAGES OF PRECLINICAL AD (2014) (0)
- A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease (2012) (0)
- Abstract 47: White Matter Atrophy in Cerebral Amyloid Angiopathy (2016) (0)
- Genotype-phenotype studies examining the CD33 locus and amyloid biology (2013) (0)
- Pittsburgh compound B binding and MRI findings in nondemented hypertensive patients with cognitive concerns or mild cognitive impairment (2013) (0)
- Regional FDG hypometabolism associated with amyloid deposition in normal aging (2007) (0)
- Association of Age at Menopause and Hormone Therapy Use With Tau and β-Amyloid Positron Emission Tomography. (2023) (0)
- The combined influence of beta‐amyloid and vascular risk on prospective brain atrophy in clinically normal individuals (2021) (0)
- P1-221: Amyloid deposition related to cortical thinning (2008) (0)
- Cross-sectional cerebral volumetric differences and associations with estimated time to age-at-onset in familial Alzheimer's disease: Findings from the DIAN study (2012) (0)
- In-vivo cortical distributions of tau and amyloid in cognitively normal individuals (2016) (0)
- SUBJECTIVE COGNITIVE DECLINE, LONGITUDINAL COGNITIVE PERFORMANCE, AND IMAGING BIOMARKERS IN PRECLINICAL ALZHEIMER’S DISEASE (2017) (0)
- Amyloid Imaging in Alzheimer Disease (2006) (0)
- Functional activities questionnaire items that best predict disease progression in the clinically normal elderly (2013) (0)
- Are amyloid and tau synergistic? How to interpret an amyloid/tau interaction on cognitive decline in clinically normal adults (2020) (0)
- ASSOCIATIONS BETWEEN MEASURES OF MEDIAL TEMPORAL LOBE NEURODEGENERATION AND ANOSOGNOSIA FOR MEMORY DEFICITS (2017) (0)
- Amyloid‐β and tau pathologies relate to distinctive brain dysconnectomics in autosomal‐dominant Alzheimer’s disease (2021) (0)
- SUBJECTIVE COGNITIVE DECLINE PREDICTS LONGITUDINAL DECLINE IN THOSE WITH BOTH AMYLOIDOSIS AND NEURODEGENERATION (2016) (0)
- Evidence for dissociable patterns of PiB retention during early stages of amyloid accumulation (2012) (0)
- DISTINCT CONTRIBUTIONS OF BASELINE AND LONGITUDINAL AMYLOID PET MEASURES TO MEMORY DECLINE IN COGNITIVELY NORMAL OLDER ADULTS (2019) (0)
- ASSOCIATIONS OF REGIONAL CORTICAL THINNING AND LONGITUDINAL COGNITIVE PERFORMANCE IN THE CONTEXT OF AMYLOID IN CLINICALLY NORMAL OLDER ADULTS (2019) (0)
- Regional beta‐amyloid and tau deposition: Results from the Framingham Heart Study (2021) (0)
- Cognitive‐behavioral associations of amygdala subregional tau pathology in cognitively unimpaired Presenilin‐1 E280A mutation carriers (2022) (0)
- REGIONAL FLUORODEOXYGLUCOSE HYPOMETABOLISM IS ASSOCIATED WITH GREATER APATHY OVER TIME IN EARLY ALZHEIMER'S DISEASE (2016) (0)
- Amyloid+ clinically normal individuals with elevated tau show greatest decline (2016) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- Neuropsychological test performance of former American football players (2023) (0)
- Alzheimer’s disease biomarker roadmap 2020: [18F]flortaucipir (2020) (0)
- COVARYING SPATIAL PATTERNS OF TAU DEPOSITION AND GRAY MATTER ATROPHY UNEARTHED BY THE INFORMED MULTIMODAL PARTIAL LEAST SQUARES (MMPLS) IN AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: FINDINGS FROM THE COLBOS PROJECT (2019) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- OPTIMAL MEMORY PERFORMANCE IN OLDER ADULTS IS ASSOCIATED WITH DIFFERENCES IN HIPPOCAMPAL VOLUME AND AMYLOID STATUS AT BASELINE AND OVER 3 YEARS (2016) (0)
- Amyloid, apolipoprotein E (APOE) and age in relation to longitudinal FDG metabolism and clinical decline in cognitively normal and mildly impaired elderly (2013) (0)
- AN APOEε4 DERIVED STATISTICAL METHOD FOR OPTIMIZING TARGET AND REFERENCE REGIONS FOR AMYLOID-PET IMAGING (2018) (0)
- O1-05-01 Cortical amyloid deposition related to failure of hippocampal activation (2007) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- TAU ACCUMULATION IN RHINAL CORTEX IS ASSOCIATED WITH MEMORY PERFORMANCE IN NONDEMENTED YOUNG ADULTS WITH AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE (2018) (0)
- Abstract 6: The Effect of Vascular Amyloid on White Matter Disease is Mediated by Vascular Dysfunction in Cerebral Amyloid Angiopathy (2021) (0)
- CerebralPerfusionin ProgressiveSupranuclear Palsy (1992) (0)
- MRI Measures of Brain Atrophy in Frontotemporal Lobar Degeneration (2009) (0)
- Ab in cognitively normal adults is associated with accelerated cognitive aging, increased structural brain decline and alterations to functional brain activation patterns in diverse fMRI tasks. Repli- cation of nonlinear trajectories of beta-amyloid effects on the brain (2019) (0)
- Prediction of AD using MRI/SPECT (2000) (0)
- Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease (2019) (0)
- Amygdala tau pathology in preclinical autosomal dominant Alzheimer’s disease (2021) (0)
- Locus coeruleus integrity as a proxy of initial tau burden: in vivo versus ex vivo observations (2021) (0)
- The relationship between everyday functioning and cerebral tau burden in cognitively normal older adults (2022) (0)
- Longitudinal amyloid and tau accumulation in autosomal dominant Alzheimer’s disease: findings from the Colombia-Boston (COLBOS) biomarker study (2021) (0)
- CONNECTIVITY TRAJECTORIES IN NORMAL AGING, MCI AND AD RACE MODIFIES FUNCTIONAL CONNECTIVITY OF THE DEFAULT MODE NETWORK IN AGING AND ALZHEIMER’S DISEASE (2018) (0)
- The relationship between cortical atrophy and tau pathology measured in vivo with [18F] T807 PET (2015) (0)
- Plasma levels of an N‐terminal tau fragment are highly associated with future cognitive decline and neurodegeneration in clinically normal elderly (2020) (0)
- ASSOCIATION BETWEEN REGIONAL AMYLOID AND REGIONAL TAU IN YOUNGER, NON-DEMENTED INDIVIDUALS IN THE FRAMINGHAM HEART STUDY (2018) (0)
- Longitudinal hippocampal atrophy is associated with an amyloid‐independent entorhinal tauopathy and an amyloid‐dependent neocortical tauopathy (2020) (0)
- Cognitive follow-up in non-demented subjects with evidence of amyloid deposition using Pittsburgh Compound-B (PIB) (2007) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- Faster rates of tau accumulation in FTP‐PET in females relative to males, and a cross‐sectional influence on faster cognitive decline: Preliminary findings from HABS and ADNI (2020) (0)
- Challenging tests of memory are more sensitive to detect effects of amyloid deposition in normal elderly subjects (2009) (0)
- AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains. (2022) (0)
- THINNING AND LONGITUDINAL COGNITIVE PERFORMANCE IN THE CONTEXT OF AMYLOID IN CLINICALLY NORMAL OLDER ADULTS (2019) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- Trajectories of decline in cognitively complex everyday activities across the Alzheimer’s disease continuum (2020) (0)
- PET STAGING OF AMYLOIDOSIS: EVIDENCE THAT AMYLOID OCCURS FIRST IN NEOCORTEX AND LATER IN STRIATUM (2016) (0)
- Abstract 69: Extent Of Tau And Its Cognitive Implications In Cerebral Amyloid Angiopathy (2022) (0)
- Tau accumulation observed using repeated PET measures is associated with cognitive decline in normal elderly (2018) (0)
- SORTOUT‐AB: A Study of Race to Understand Alzheimer Biomarkers (2022) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- SPECIFIC FEATURES OF SUBJECTIVE COGNITIVE DECLINE ARE RELATED TO AMYLOID AND TAU PATHOLOGY IN COGNITIVELY HEALTHY OLDER ADULTS (2019) (0)
- HEALTHYAGING AND ALZHEIMER ’ S DISEASE , AND POSSIBLE REMEDIES (2014) (0)
- INTERACTIVE ASSOCIATION OF LIVING ALONE AND AMYLOID-Β BURDEN WITH LONGITUDINAL COGNITION IN COGNITIVELY UNIMPAIRED OLDER ADULTS (2020) (0)
- Instrumental Activities of Daily Living Impairment Is Associated with Temporal and Parietal Hypometabolism in Mild Cognitive Impairment (P04.214) (2012) (0)
- Baseline amyloid PET imaging, longitudinal amyloid accumulation, and Tau PET imaging in preclinical Alzheimer's disease (2015) (0)
- Reclaiming Pension Fund Fiduciary Duty (2016) (0)
- P2-240 Prediction of clinical stability vs. progression in questionable ad using perfusion spect (2004) (0)
- TAU AND AMYLOID PET IMAGING IN A COLOMBIAN KINDRED WITH AUTOSOMAL-DOMINANT ALZHEIMER'S DISEASE (2016) (0)
- Association of Carotid Intima Media Thickening with Future Brain Region Specific Amyloid-β Burden. (2022) (0)
- Using a digital assessment of multi‐day learning curves to detect preclinical AD (2022) (0)
- Association of tau tangle burden with depressive symptoms in community‐dwelling older adults: A longitudinal study (2020) (0)
- ANXIETY, SUBJECTIVE COGNITIVE DECLINE, AND CORTICAL AMYLOID IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE: A PRELIMINARY REPORT (2017) (0)
- THE EFFECT OF TRACT-SPECIFIC LOSS OF WHITE MATTER CONNECTIVITY ON COGNITIVE DECLINE IN HEALTHY OLDER INDIVIDUALS DEPENDS ON ENTORHINAL T807 BINDING (2016) (0)
- TAUACCUMULATIONINRHINALCORTEXISASSOCIATEDWITHMEMORY PERFORMANCE IN NON-DEMENTED YOUNG ADULTS WITH AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2018) (0)
- WHITE MATTER BURDEN IN CLINICALLY NORMAL OLDER ADULTS MEDIATES THE RELATIONSHIP BETWEEN AMYLOID BURDEN AND MEMORY FREE RECALL BUT NOT CUED RECALL (2014) (0)
- Association of Apathy with Amyloid‐β and Tau in Cognitively Unimpaired Older Adults: Findings from the Harvard Aging Brain Study (2022) (0)
- A NOVEL PERFORMANCE-BASED ADL INSTRUMENT FOR EARLYALZHEIMER’S DISEASE (2019) (0)
- O1-05-01 (2006) (0)
- Clinical and neuroimaging predictors of psychological well-being as measured by the purpose in life scale in cognitively normal older individuals (2015) (0)
- Tau and amyloid deposits relate to distinctive cortical atrophy patterns in cognitively normal elderly (2015) (0)
- omarker for assessing signals of efficacy in early-stage AD clinical trials. P2-327 NEUROIMAGE STEREOLOGY: A MARKER FOR BRAIN AGING AND DEMENTIA (2006) (0)
- Cerebrovascular injury markers explain the effect of systemic vascular risk on cognitive decline in older adults with lower amyloid burden (2022) (0)
- ASSOCIATION BETWEEN CORTICAL THINNING AND TAU PATHOLOGY IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2018) (0)
- Predictive value of visually rated tau PET imaging for amyloid status, atrophy, and syndromic diagnosis across a spectrum of neurodegenerative phenotypes (2020) (0)
- Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum (2020) (0)
- Associations Between Mild Behavioral Impairment (MBI‐C) Affective Domains and Alzheimer’s Disease Neuroimaging Biomarkers in Older Adults (2022) (0)
- QUANTITATIVE SCORING OF [18F] FLORTAUCIPIR PET SCANS IN TYPICAL AND ATYPICAL PHENOTYPES OF ALZHEIMER’S DISEASE (2018) (0)
- JOINT DEBLURRING OF LONGITUDINAL DIFFERENTIAL PET IMAGES OF TAU (2018) (0)
- Brainstem volume is negatively associated with amyloid deposition in the Framingham Heart Study (2021) (0)
- Progressive white matter abnormalities in autosomal-dominant Alzheimer's disease: Results of the DIAN study (2012) (0)
- Elevated PiB precedes dementia in autosomal-dominant Alzheimer's disease: PiB, FDG and atrophy in the DIAN cohort (2012) (0)
- Location, location, location: The distributed effects of amyloid on functional connectivity in the harvard aging brain study (2015) (0)
- Differential anatomical correlates of objective and subjective memory in older individuals across a spectrum of memory impairment (2013) (0)
- Increased amyloid deposition and parental history of Alzheimer's disease is related to altered default network activity during successful encoding in cognitively normal older adults (2011) (0)
- TAU AND AMYLOID PET IMAGING IN A COLOMBIAN KINDRED WITH AUTOSOMAL-DOMINANT ALZHEIMER'S DISEASE (2016) (0)
- Distinct contributions of longitudinal tau and amyloid to decline in various cognitive domains in preclinical AD (2020) (0)
- IC-101-05 fMRI alterations in medial temporal and default mode activity in MCI and AD (2006) (0)
- NEUROIMAGING CORRELATES OF ANOSOGNOSIA IN MILD COGNITIVE IMPAIRMENT (2016) (0)
- P3-397 THE RELATIONSHIP BETWEEN BETA- AMYLOID AND VASCULAR HEALTH IN OLDER ADULTS (2018) (0)
- SEX AND APOE GENOTYPE INFLUENCE THE ASSOCIATION BETWEEN AMYLOID AND LONGITUDINAL TAU PATHOLOGY IN CLINICALLY NORMAL OLDER ADULTS: FINDINGS FROM THE ADNI STUDY (2018) (0)
- IC-P-056 INTERACTION EFFECT OFAPOE-4 AND SUBJECTIVE SLEEP QUALITY ON CORTICALTHICKNESS IN COGNITIVELY HEALTHYADULTS (2019) (0)
- Longitudinal tau burden partially mediates synergistic influence of vascular risk and amyloid‐beta on cognitive decline in clinically normal older adults (2022) (0)
- The dynamic interplay between longitudinal subjective and objective cognitive decline along the early AD spectrum in the Harvard Aging Brain Study (2020) (0)
- AMYLOID-β, COGNITION AND SOCIAL ACTIVITY IN COGNITIVELY NORMAL OLDER ADULTS (2018) (0)
- SAMPLE SIZES FOR 24-MONTH ALZHEIMER’S PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS (2017) (0)
- P2-461 ENTORHINALTAU PATHOLOGY IS ASSOCIATEDWITH WHITE MATTER ABNORMALITIES IN UNCINATE FASCICULUS IN PRECLINICAL AUTOSOMAL DOMINANTALZHEIMER’S DISEASE (2018) (0)
- LONGITUDINAL PET MEASURES OF TAU AND AMYLOID ACCUMULATION IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE: FINDINGS FROM THE COLBOS PROJECT (2019) (0)
- Monthly computerized at‐home assessments to detect cognitive change in preclinical Alzheimer’s disease (2021) (0)
- Longitudinal trajectories of remote assessment of self‐ and study partner‐rated cognitive concerns, mood and Alzheimer’s disease biomarkers (2021) (0)
- Abstract 103: Cortical tau Pathology in Cerebral Amyloid Angiopathy (2019) (0)
- Amyloid deposition and brain volume across the continuum of aging and Alzheimer's Disease (2009) (0)
- NEUROPSYCHIATRIC SYMPTOMS AND FUNCTIONAL CONNECTIVITY IN MILD COGNITIVE IMPAIRMENT AND COGNITIVELY NORMAL ELDERLY (2014) (0)
- Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau (2023) (0)
- Disparities in Recruitment and Screen Failure by Race and Ethnicity in the Harvard Aging Brain Study (HABS) (2022) (0)
- OLFACTORY IDENTIFICATION AND ALZHEIMER'S DISEASE BIOMARKERS IN CLINICALLY NORMAL ELDERLY (2014) (0)
- Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants (2015) (0)
- Lower in‐vivo locus coeruleus integrity is associated with lower cortical thickness in older individuals with elevated Alzheimer’s pathology (2022) (0)
- ASSOCIATION BETWEEN REGIONAL AMYLOID AND REGIONAL TAU WITHIN YOUNGER, NON-DEMENTED INDIVIDUALS OF THE FRAMINGHAM HEART STUDY (2018) (0)
- Associations of peak width of skeletonized mean diffusivity with cardiovascular disease risk and cognitive decline in clinically normal older adults (2020) (0)
- AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains (2022) (0)
- IC-P-140 TAU ACCUMULATION AND MEMORY DECLINE ARE MORE CLOSELY RELATED TO STRIATALTHAN CORTICAL AMYLOIDOSIS IN INDIVIDUALS WITH EARLY-ONSETAUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2018) (0)
- AMYLOID BURDEN AND VASCULAR RISK ARE INDEPENDENTLY ASSOCIATED WITH SUBJECTIVE COGNITIVE DECLINE IN CLINICALLY NORMAL OLDER ADULTS (2018) (0)
- GERIATRIC DEPRESSION SCALE ITEM-LEVEL ANALYSIS IN RELATION TO IN VIVO CORTICAL AMYLOID AND CEREBRAL REGIONAL TAU IN CLINICALLY NORMAL OLDER ADULTS: FINDINGS FROM THE HARVARD AGING BRAIN STUDY (2019) (0)
- Fluctuations in reaction time performance as a marker of incipient amyloid‐related cognitive decline in clinically unimpaired older adults. (2022) (0)
- P2-328 Imaging of cerebral amyloid angiopathy with Pittsburgh Compound B (2006) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- Imaging tau pathology in vivo in ftld with [18F] T807 PET (2015) (0)
- Menopause age and hormone therapy use moderate PET tau and amyloid association: findings from the Wisconsin Registry for Alzheimer Prevention (2022) (0)
- P3â•’370: AN APOEÎμ4 DERIVED STATISTICAL METHOD FOR OPTIMIZING TARGET AND REFERENCE REGIONS FOR AMYLOIDâ•’PET IMAGING (2018) (0)
- Disrupted functional connectivity in autosomal dominant Alzheimer’s disease demonstrates network specificity and precedes brain volume loss: Findings from DIAN (2013) (0)
- Longitudinal hippocampal atrophy is associated with cognitive decline independently of amyloid and tau in neocortex (2022) (0)
- A-05 The Latin American Spanish Version of the Face-Name Associative Memory Exam is Sensitive to Cognitive and Pathological Changes in Preclinical Autosomal Dominant Alzheimer’s Disease (2020) (0)
- Memory impairment is a clinical marker of tau pathology in cerebral amyloid angiopathy (2020) (0)
- P4-299 TAU ACCUMULATION IN THE ENTORHINAL CORTEX AND PRECUNEUS IS ASSOCIATEDWITH CORTICAL AMYLOID-BETA BURDEN, AGE AND WORSE MEMORY PERFORMANCE IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (0)
- IC-103-03 Amyloid deposition in presymptomatic familial Alzheimer’s disease (2006) (0)
- Associations between biomarker status (amyloid, tau) and risk for progression to MCI/Dementia in the Harvard Aging Brain Study (2021) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- Entorhinal thickness mediates the relationship between hippocampus volume and default-mode network connectivity independently of amyloid burden in cognitively intact elderly (2013) (0)
- Neuropsychiatric and cognitive factors predict progression to mild cognitive impairment and dementia (2013) (0)
- Tracking the origin of tau spread in the brain (2020) (0)
- Test-Retest Reliability of Resting State Functional Connectivity MRI in Mild Cognitive Impairment (P06.024) (2013) (0)
- The Latin American Spanish version of the Face-Name Associative Memory Exam is sensitive to cognitive and pathological changes in preclinical autosomal dominant Alzheimer’s disease (2020) (0)
- Plasma Biomarkers of Neurodegeneration and Tau in Relation to Longitudinal Depressive Symptoms in Older Adults: Findings from the Harvard Aging Brain Study (2022) (0)
- SYNERGISTIC ADVERSE EFFECTS OF WIDOWHOOD AND AMYLOID-β ON COGNITIVE DECLINE IN COGNITIVELY NORMAL OLDER ADULTS (2019) (0)
- Alzheimer research forum live discussion: Imaging in Alzheimer's disease: the current state of affairs. (2005) (0)
- Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer’s disease (2019) (0)
- Subcortical ischemic disease is associated with regionally specific cortical atrophy distinct from that seen in Alzheimer's disease (2013) (0)
- may yield important insights into genetic influences on the biology of Alzheimer’s disease (AD).We investigated the accuracy of a novel unsuper- vised multimodal biomarker classifier for differentiating cognitively normal elderly (NC) from subjects with amnestic mild cognitive impairment (2019) (0)
- Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy (2022) (0)
- APOE4 potentiates amyloid effect on tau deposition in clinically normal older individuals (2016) (0)
- PREDICTING AMYLOID BURDEN IN SCREENING FOR PRECLINICAL AD PREVENTION TRIALS (2018) (0)
- Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
- The relationship of cognition, cognitive reserve, and in vivo tau and amyloid burden (2015) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- TAU ACCUMULATION AND VISUAL MEMORY IN COGNITIVELY UNIMPAIRED PSEN1 E280A MUTATION CARRIERS (2019) (0)
- TAU ACCUMULATION IS DETECTABLE AND CORRELATED TO AMYLOID BURDEN IN NORMAL AND IMPAIRED OLDER INDIVIDUALS USING SERIAL PET (2017) (0)
- IC-P2-139: Longitudinal fMRI demonstrates loss of hippocampal function associated with clinical decline in non-demented older subjects (2008) (0)
- BASELINE CARDIOVASCULAR RISK AND AMYLOID BURDEN SYNERGISTICALLY PREDICT LONGITUDINAL COGNITIVE DECLINE IN CLINICALLY NORMAL ELDERLY: FINDINGS FROM THE HARVARD AGING BRAIN STUDY (2017) (0)
- IC-P-040 FUNCTIONALNETWORKCONNECTIVITY CHANGES IN EARLYAND LATE ONSET ALZHEIMER’S DISEASE (2018) (0)
- ENTORHINAL TAU PATHOLOGY IS ASSOCIATED WITH WHITE MATTER ABNORMALITIES IN UNCINATE FASCICULUS IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER’S DISEASE (2018) (0)
- Sequential early cognitive changes sensitive to rising beta‐amyloid and tau pathology in preclinical AD (2021) (0)
- Surface‐based amyloid and tau correlates of digital clock drawing performance (2020) (0)
- 44% of CDR 0 persons, did not correlate with onset or progression of Alzheimer dementia, in contrast to the accurate prediction of future onset of AD dementia by informant reports of memory prob- (2019) (0)
- Plasma levels of an N‐terminal tau fragment predict core AD and neurodegenerative biomarkers in autosomal dominant Alzheimer’s disease: Findings from DIAN (2022) (0)
- FREE AND CUED MEMORY IS DISTINCTLY RELATED TO PATHOLOGY IN PRECLINICAL AUTOSOMAL-DOMINANT ALZHEIMER’S DISEASE (2019) (0)
- Visual short-term memory relates to tau and amyloid burdens in preclinical autosomal dominant Alzheimer’s disease (2020) (0)
- Predictive modeling of tau aggregation and propagation using PET and DTI (2020) (0)
- Regional Tau PET measures associated with memory performance in clinically normal older individuals (2015) (0)
- Associations between plasma p‐tau217, in vivo brain pathology and cognition in individuals with autosomal‐dominant Alzheimer’s disease: Findings from the Colombia‐Boston (COLBOS) biomarker study (2021) (0)
- Baseline amyloid PET imaging, longitudinal amyloid accumulation, and Tau PET imaging in preclinical Alzheimer's disease (2015) (0)
- Longitudinal inferior temporal FTP‐PET signal increase is associated with contemporaneous longitudinal temporal lobe cortical thinning in preclinical Alzheimer’s disease (2020) (0)
- Association between the Harvard automated phone task and Alzheimer’s disease pathology in clinically normal older adults (2021) (0)
- DECREASED META-MEMORY FOR EPISODIC BUT NOT SEMANTIC INFORMATION IS ASSOCIATED WITH EARLY TAUOPATHY IN CLINICALLY NORMAL OLDER ADULTS (2018) (0)
- HETEROGENEITY IN NEUROIMAGING PATTERNS PRESENT THROUGHOUT THE CLINICAL SPECTRUM OF TYPICAL LATE-ONSET AMNESTIC AD (2017) (0)
- Differential declines in letter versus category fluency over 4 years in biomarker-defined preclinical Alzheimer’s disease (2015) (0)
- APOE ε4 effects on florbetapir F18 PET in Alzheimer's disease, mild cognitive impairment and normal aging (2011) (0)
- ANATOMICAL STAGING OF BETA-AMYLOID ACCUMULATION BASED ON LONGITUDINAL ASSESSMENT OF GLOBALLY PIB NEGATIVE ADULTS (2019) (0)
- Neurobiological correlates of anosognosia in mild cognitive impairment: A multimodal investigation using FDG-PET, PiB-PET, and volumetric MRI (2015) (0)
- A voxel-based morphometry study of volumetric MRI in familial Alzheimer's disease (2012) (0)
- REGIONAL FLUORODEOXYGLUCOSE HYPOMETABOLISM IS ASSOCIATED WITH GREATER APATHY OVER TIME IN EARLY ALZHEIMER'S DISEASE (2016) (0)
- Defining the ATN framework using longitudinal biomarker trajectories reveals an emerging amyloid accumulation group (2022) (0)
- P2-329 Amyloid burden correlates with cognitive function in normal aging, MCI and AD (2006) (0)
- Evidence for dissociable patterns of PiB retention during early stages of amyloid accumulation (2012) (0)
- Elevated tau‐PET signal predicts near‐term conversion to mild cognitive impairment in cognitively unimpaired older adults (2022) (0)
- A longitudinal analysis of depressive symptoms in relation to repeated measurements of regional tau (2022) (0)
- AV1451 TAU TRACER UPTAKE CORRELATES WITH HIPPOCAMPAL CA1 SUBFIELD ATROPHY IN AMYLOID- NEGATIVE INDIVIDUALS (2018) (0)
- OLFACTORY IDENTIFICATION AND ALZHEIMER'S DISEASE BIOMARKERS IN CLINICALLY NORMAL ELDERLY (2014) (0)
- Location, location, location: The distributed effects of amyloid on functional connectivity in the harvard aging brain study (2015) (0)
- COGNITIVE RESERVE RELATES TO GREATER FUNCTIONAL CONNECTIVITY AND STRONGER INTERCONNECTIVITY WITHIN AND BETWEEN NODES, INDEPENDENT OF β-AMYLOID: FINDINGS FROM THE HARVARD AGING BRAIN STUDY (2017) (0)
- IN VIVO SPREADING PATHWAYS OF TAU AND AMYLOID ACCUMULATION AND ITS GENETIC UNDERPINNINGS (2017) (0)
- Key Words: neural network;cerebral perfusionimaging (2006) (0)
- Strategies for diverse participant recruitment to a preclinical Alzheimer’s Disease prevention trial: The AHEAD study (2022) (0)
- ANATOMICAL STAGING OF BETA-AMYLOID ACCUMULATION BASED ON LONGITUDINAL ASSESSMENT OF GLOBALLY PIB NEGATIVE ADULTS (2019) (0)
- White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimerâ•Žs disease (2019) (0)
- Covariate : Application to an Alzheimer ’ s Study (2015) (0)
- Maternal history of dementia is associated with amyloid deposition and brain glucose hypometabolism in cognitively normal and mildly impaired elderly (2011) (0)
- BRAIN RESILIENCE PROTECTS AGAINST COGNITIVE DECLINE ASSOCIATED WITH ELEVATED AMYLOID BURDEN (2018) (0)
- SAMPLE SIZES FOR 24-MONTH ALZHEIMER’S PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID-POSITIVE ADULTS (2017) (0)
- OPTIMIZING COGNITIVE OUTCOMES FOR BIOMARKER POSITIVE INDIVIDUALS AT DIFFERENT CLINICAL STAGES OF ALZHEIMER’S DISEASE ACCORDING TO THE NIA-AA RESEARCH FRAMEWORK (2019) (0)
- Computerized cognitive practice effects in relation to amyloid and tau in preclinical Alzheimer's disease: Results from a multi‐site cohort (2023) (0)
- PAYATTENTION TO THE BASAL GANGLIA: AVOLUMETRIC STUDY IN EARLY DEMENTIAWITH LEWY BODIES (2018) (0)
- Plasma ptau231 predicts locus coeruleus integrity earlier in life than other Alzheimer’s disease plasma markers: a 7T MRI study across the adult lifespan (2022) (0)
- Comparison of multiple neuropsychological models to predict amyloid deposition (2011) (0)
- CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER’S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID (2019) (0)
- Developing early vulnerable area aggregates for PET detection of beta‐amyloid based on young and middle‐aged adults from the Framingham Heart Study (2022) (0)
- Cortical microstructure is associated with tau burden and predicts cognitive decline and clinical progression in healthy older adults (2021) (0)
- The location of PSEN1 pathogenic variants in transmembrane vs. cytoplasmic domains may alter neurodegenerative and cognitive trajectories: Findings from the DIAN study (2021) (0)
- FDG metabolism in the DIAN study of autosomal dominant Alzheimer's disease (2012) (0)
- Paired associative learning is related to amyloid deposition in normal older individuals. (2011) (0)
- The relationship between cortical microstructural changes and in vivo amyloid‐β and tau in aging and preclinical Alzheimer's disease (2020) (0)
- Amyloid, Tau, and Functional connectivity (2016) (0)
- APOE E4 effects on florbetapir F18 PET in Alzheimer's disease, mild cognitive impairment and normal aging (2011) (0)
- Attenuation Correction for Amyloid PET Imaging Using Deep Learning Based on 3D UTE/Multi-Echo Dixon MR images (2020) (0)
- RELATIONSHIPS BETWEEN MEMORY FUNCTION, TAU PATHOLOGY AND FUNCTIONAL CONNECTIVITY IN THE DEFAULT MODE NETWORK IN AUTOSOMAL-DOMINANT ALZHEIMER’S DISEASE: A PRELIMINARY REPORT (2017) (0)
- THE RELATIONSHIP BETWEEN RECALL OF RECENTLY VERSUS REMOTELY ENCODED FAMOUS FACES AND AMYLOID AND TAU BURDEN IN CLINICALLY NORMAL OLDER ADULTS (2017) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- Evidence that striatal amyloidosis is a marker of disease progression across the spectrum of Alzheimer's disease (2016) (0)
- CLINICAL MEANINGFULNESS OF SHORT-TERM COGNITIVE DECLINE ON THE PRECLINICAL ALZHEIMER’S COGNITIVE COMPOSITE-5 (PACC-5) IN NORMAL OLDER ADULTS WITH ELEVATED β-AMYLOID (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Keith A Johnson?
Keith A Johnson is affiliated with the following schools:
